Community-Based Pharmacotherapy for Depression
In low-income countries, high prevalence of depression is paired with a severe shortage of healthcare providers, leaving only 15 percent of individuals with depression in India receiving necessary care. Community-based provision of pharmacotherapy attempts to bridge this treatment gap to improve psychological well-being and economic outcomes.
Picture this
Imagine a village where water pipes are clogged, leaving homes without water because central plumbers rarely visit. Instead of waiting for central engineers, local health workers deliver simple unclogging tools directly to residents, restoring water flow right at home without needing a massive new reservoir.
What the evidence says
Psychiatric Care reduced depression symptoms by 0.14 standard deviations during treatment, but decreased participants' work time by 5.4 hours per week (a 10 percent reduction) during the intervention without increasing earnings.
- Who
- N = 1,000 adults with symptoms of mild or moderate depression (86 percent women) recruited from 506 villages near Bangalore, India [3, 4].
- How
- Randomized evaluation assigning participants to Psychiatric Care, Livelihoods Assistance, Combined Treatment, or Comparison groups with five surveys between 2016 and 2018 up to 26 months post-recruitment [4-6].
What to do
Establish community-based psychiatric screening and monthly local medication monitoring protocols to deliver localized pharmacotherapy to low-income populations.
From the source
"Although India's Mental Health Care Act of 2017 guarantees its citizens a right to mental health care, only 15 percent of people with depression receive the necessary care."
The_Impacts_of_Mental_Health_Treatment_on_Productivity_in_India.pdf